HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Koshi Akahane Selected Research
Koshi Akahane Research Topics
Disease
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024 - 08/2005
18
Leukemia
01/2023 - 10/2007
12
Neoplasms (Cancer)
04/2024 - 10/2010
8
Philadelphia Chromosome
04/2024 - 07/2011
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
11/2023 - 10/2010
4
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2023 - 01/2020
2
Neuroblastoma
12/2019 - 01/2016
1
Bites and Stings (Sting)
10/2023
1
Genomic Instability
10/2023
1
Hemorrhagic Cystitis
03/2022
1
Diarrhea
03/2022
1
Graft vs Host Disease (Graft-Versus-Host Disease)
03/2022
1
Infections
03/2022
1
Sepsis (Septicemia)
03/2022
1
Abdominal Pain (Pain, Abdominal)
03/2022
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022
1
Wolf-Hirschhorn Syndrome
01/2022
1
Glucocorticoid Receptor Deficiency
01/2022
1
Lymphoma (Lymphomas)
12/2021
1
Multiple Myeloma
06/2021
1
Residual Neoplasm
01/2021
1
Chromosome Aberrations (Chromosome Abnormalities)
11/2020
1
Splenomegaly
01/2019
1
Juvenile Myelomonocytic Leukemia
01/2019
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018
1
Myeloid Leukemia (Leukemia, Myelocytic)
01/2018
1
Hypertrophy
01/2016
Drug/Important Bio-Agent (IBA)
8
Proteins (Proteins, Gene)
FDA Link
05/2023 - 08/2015
7
Tyrosine Kinase Inhibitors
IBA
04/2024 - 01/2018
5
Imatinib Mesylate (Gleevec)
FDA Link
10/2022 - 07/2011
4
Transcription Factors (Transcription Factor)
IBA
07/2020 - 08/2010
3
Phosphotransferases (Kinase)
IBA
10/2023 - 01/2018
3
Biomarkers (Surrogate Marker)
IBA
11/2022 - 01/2017
3
Ligands
IBA
01/2013 - 10/2010
2
Integrins
IBA
04/2024 - 01/2020
2
Asparaginase (Elspar)
FDA Link
11/2022 - 11/2020
2
Janus Kinases
IBA
12/2021 - 08/2015
2
Death Domain Receptors
IBA
01/2021 - 07/2011
2
blinatumomab
IBA
01/2021 - 01/2021
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
07/2011 - 10/2010
1
Laminin (Merosin)
IBA
04/2024
1
Sucrose (Saccharose)
IBA
11/2023
1
Interferons
IBA
10/2023
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
05/2023
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
05/2023
1
Phosphatidylinositol 3-Kinases (PI 3 Kinase)
IBA
05/2023
1
olaparib
IBA
05/2023
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
04/2023
1
CC-90009
IBA
01/2023
1
ruxolitinib
IBA
01/2023
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
01/2023
1
Aspartate-Ammonia Ligase (Asparagine Synthetase)
IBA
11/2022
1
hydrogen sulfite (bisulfite)
IBA
11/2022
1
Poly (ADP-Ribose) Polymerase-1
IBA
10/2022
1
Immunosuppressive Agents (Immunosuppressants)
IBA
03/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
03/2022
1
Beclomethasone (Beclometasone)
FDA Link
03/2022
1
CREB-Binding Protein
IBA
01/2022
1
Glucocorticoid Receptors (Glucocorticoid Receptor)
IBA
01/2022
1
Carrier Proteins (Binding Protein)
IBA
01/2022
1
Histone Acetyltransferases (Histone Acetyltransferase)
IBA
01/2022
1
Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)
IBA
01/2022
1
Glucocorticoids
IBA
01/2022
1
Proteolysis Targeting Chimera
IBA
12/2021
1
2-mercaptopurine
IBA
11/2021
1
Lenalidomide (CC 5013)
FDA Link
06/2021
1
Protein Isoforms (Isoforms)
IBA
06/2021
1
Immunomodulating Agents
IBA
06/2021
1
TNF-Related Apoptosis-Inducing Ligand
IBA
01/2021
1
Chimeric Antigen Receptors
IBA
01/2021
1
Fibronectins (Fibronectin)
IBA
01/2020
1
Adrenergic Agents (Adrenergic Drugs)
IBA
12/2019
1
nelarabine (506U78)
FDA Link
10/2019
1
thymoglobulin
FDA Link
01/2019
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2019
1
Tranylcypromine (Parnate)
FDA Link
Generic
01/2019
1
Lysergic Acid Diethylamide (LSD)
IBA
01/2019
1
Luciferases
IBA
01/2019
1
Poly Adenosine Diphosphate Ribose
IBA
01/2018
1
Deoxycytidine Kinase
IBA
01/2018
1
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2018
1
Clofarabine (Clolar)
FDA Link
01/2018
1
Proteasome Inhibitors
IBA
01/2017
1
tofacitinib
IBA
01/2017
1
Bortezomib (Velcade)
FDA Link
01/2017
1
Janus Kinase Inhibitors
IBA
01/2017
1
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
01/2017
1
p38 Mitogen-Activated Protein Kinases
IBA
01/2017
1
TYK2 Kinase (Tyrosine Kinase 2)
IBA
01/2017
1
baricitinib
IBA
01/2017
1
Cyclin D2
IBA
01/2016
Therapy/Procedure
10
Therapeutics
04/2024 - 02/2010
5
Drug Therapy (Chemotherapy)
04/2024 - 08/2005
4
Transplantation
01/2022 - 02/2010
3
Hematopoietic Stem Cell Transplantation
03/2022 - 04/2004
2
Stem Cell Transplantation
10/2010 - 04/2004
1
Precision Medicine
01/2022
1
Immunotherapy
01/2021
1
Oral Administration
01/2017
1
Combination Drug Therapy (Combination Chemotherapy)
01/2017